Saturday, May 30, 2020

Medical Cannabis News

Health Europa brings you the latest Medical Cannabis News from across the field of European Healthcare & Social Care Policy.

Research to look at cannabis landraces for treating gastrointestinal cancers

Research to look at cannabis landraces for treating gastrointestinal cancers

A new research partnership has been set up to look at the efficacy of cannabis landraces for gastrointestinal cancers to help inform cannabinoid profile...
New cannabis research partnership to look at cannabis for medical use

New cannabis research partnership to look at cannabis for medical use

A new cannabis research partnership will identify and analyse pharmacological, agricultural and genetic characteristics of 240 cannabis varieties for therapeutic purposes, such as refractory...
Study reveals difference between labelled and actual CBD potency

Study reveals difference between labelled and actual CBD potency

A scientific study has revealed differences between the CBD potency labelled on products and actual potency when measured. GemmaCert has revealed the results of a...
The UK’s first operational distance medical cannabis pharmacy launches

The UK’s first operational distance medical cannabis pharmacy launches

The UK’s first operational distance medical cannabis pharmacy has now launched, dedicated to fulfilling medical cannabis prescriptions. EMMAC Life Sciences Group, Europe’s leading independent cannabis...
CBD market on course to grow 400% in Europe alone 

CBD market on course to grow 400% in Europe alone 

Over the next five years, the global CBD market is expected to accelerate to $23.6bn, according to Grand View Research and Europe's CBD market...
Applying data to address Europe’s burgeoning CBD market

Applying data to address Europe’s burgeoning CBD market

The European CBD market remains immature, and little data has been available to CBD brands seeking to understand consumers, here New Frontier Data share...
CBD in Europe report: making the single market real

CBD in Europe report: making the single market real

Pan-European Association, ACTIVE has launched its first English-speaking report: CBD in Europe — Making the Single Market Real. The report is the second ACTIVE report,...
Over 99% of patients able to reduce symptoms using medical cannabis

Over 99% of patients able to reduce symptoms using medical cannabis

Results from a survey of medical cannabis patients showed that over 99% of patients confirmed they have reduced symptoms using medical cannabis. Compassionate Certification Centers,...
The evolution of the American cannabis industry in the last decade

The evolution of the American cannabis industry in the last decade

The American cannabis industry squinted into daylight as it emerged into a billion-dollar industry coming from a black market background. Since then, it is...
Past and future: the growth of CBD medicine

Past and future: the growth of CBD medicine

Even in the last decade of the past millennium, CBD medicine was criminalised and banned in many countries. So, what caused such a drastic...
ProPharma: seven things to consider in medical cannabis development

ProPharma: seven things to consider in medical cannabis development

ProPharma Group takes a look at medical cannabis regulation and compliance. Jan Zorgdrager, PhD, and Marc Stegeman, MSc, Principal Consultants in ProPharma Group’s Life Sciences...
B3 Labs responds to FSA CBD deadline announcement

B3 Labs responds to FSA CBD deadline announcement

Last week The Food Standards Agency (FSA) formally issued a definitive timeline for Novel Food applications setting a deadline for the 31 March 2021...

Medical Cannabis eBooks

Medical Cannabis Partners

Pin It on Pinterest